Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J; TADS Team. Kratochvil C, et al. Among authors: casat c. J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8. doi: 10.1097/01.chi.0000237710.73755.14. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17135986 Clinical Trial.
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robins M, March J; TADS Team. Vitiello B, et al. Among authors: casat c. J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1419-26. doi: 10.1097/01.chi.0000242229.52646.6e. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17135987 Clinical Trial.
Treatment for Adolescents with Depression Study (TADS): safety results.
Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J; Columbia Suicidality Classification Group; TADS Team. Emslie G, et al. Among authors: casat c. J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1440-55. doi: 10.1097/01.chi.0000240840.63737.1d. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17135989 Free PMC article. Clinical Trial.
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
Kennard BD, Silva SG, Mayes TL, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke MA, March JS; TADS. Kennard BD, et al. Am J Psychiatry. 2009 Mar;166(3):337-44. doi: 10.1176/appi.ajp.2008.08040487. Epub 2009 Jan 15. Am J Psychiatry. 2009. PMID: 19147693 Free PMC article. Clinical Trial.
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D; Atomoxetine/Methylphenidate Comparative Study Group. Newcorn JH, et al. Among authors: casat cd. Am J Psychiatry. 2008 Jun;165(6):721-30. doi: 10.1176/appi.ajp.2007.05091676. Epub 2008 Feb 15. Am J Psychiatry. 2008. PMID: 18281409 Clinical Trial.
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Michelson D, et al. Among authors: casat c. Am J Psychiatry. 2002 Nov;159(11):1896-901. doi: 10.1176/appi.ajp.159.11.1896. Am J Psychiatry. 2002. PMID: 12411225 Clinical Trial.
Bupropion hydrochloride in attention deficit disorder with hyperactivity.
Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J. Conners CK, et al. Among authors: casat cd. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314-21. doi: 10.1097/00004583-199610000-00018. J Am Acad Child Adolesc Psychiatry. 1996. PMID: 8885585 Clinical Trial.
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
Spencer TJ, Kratochvil CJ, Sangal RB, Saylor KE, Bailey CE, Dunn DW, Geller DA, Casat CD, Lipetz RS, Jain R, Newcorn JH, Ruff DD, Feldman PD, Furr AJ, Allen AJ. Spencer TJ, et al. Among authors: casat cd. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):689-700. doi: 10.1089/cap.2006.0100. J Child Adolesc Psychopharmacol. 2007. PMID: 17979588
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Wilens TE, et al. Among authors: casat c. Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90. doi: 10.1001/archpedi.160.1.82. Arch Pediatr Adolesc Med. 2006. PMID: 16389216 Clinical Trial.
36 results